A number of studies showed that high serum leptin level was associated with increased risk of endometrial cancer (Petridou et al., 2002; Cymbaluk et al., 2008; Wang et al., 2014; Cymbaluk-Płoska et al., 2018). Here, LEP is linked to endometrial cancer.